EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY-NC 4.0

Post-Percutaneous Transluminal Coronary Angioplasty Acute Dyspnea in Acute Coronary Syndrome Patients: Ticagrelor versus Clopidogrel at Tertiary Cardiac Center: A Cross-Sectional Study

Tehreem Ashraf, Qamar Uz Zaman Bhatti, Muhammad Bilal Siddique, Huma Mushtaq, Hira Ahmed, Javeria Kamran

Life and Science · 06.07.2026 · 7 (3) · 7

DOI: 10.37185/lns.1.1.1185 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Life and Science, online erschienen am 06.07.2026. Verfasst von Tehreem Ashraf und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To compare the frequency of new-onset acute dyspnea in acute coronary syndrome patients undergoing PTCA receiving Ticagrelor versus Clopidogrel.Study Design: Quasi-experimental study.Place and Duration of Study: This study was conducted at the Department of Adult Cardiology, Armed Forces Institute of Cardiology/National Institute of Heart Diseases (AFIC/NIHD), Rawalpindi, Pakistan, from 30th September 2025 to 30th March 2026.

Methods

A total of 198 male patients aged 50–75 years who underwent percutaneous transluminal coronary angioplasty (PTCA) for acute coronary syndrome (ACS) were enrolled and allocated into two groups: Experimental Group (N=99) received ticagrelor plus aspirin, and Control Group (N=99) received clopidogrel plus aspirin. Post-procedural dyspnea was assessed as the primary outcome within 8–24 hours post-procedure using the Modified Borg Acute Dyspnea Scale (0–4), with follow-up evaluations at one, two, and three months.

Results

A total of 198 male patients with ACS who underwent PTCA were included in the study. Mean patient age was 67.41±3.83 years. Dyslipidemia was the most common comorbidity, present in 140 patients (70.7%), followed by smoking in 111 (56.1%), diabetes mellitus in 104 (52.5%), and hypertension in 86 (43.4%). In hospital dyspnea was significantly more frequent with ticagrelor (57.6%) than with clopidogrel (12.1%) (P

Zitieren

APA

Ashraf, T., Bhatti, Q. U. Z., Siddique, M. B., Mushtaq, H., Ahmed, H., & Kamran, J. (2026). Post-Percutaneous Transluminal Coronary Angioplasty Acute Dyspnea in Acute Coronary Syndrome Patients: Ticagrelor versus Clopidogrel at Tertiary Cardiac Center: A Cross-Sectional Study. Life and Science, 7(3), 7. https://doi.org/10.37185/lns.1.1.1185

Vancouver

Ashraf T, Bhatti QUZ, Siddique MB, Mushtaq H, Ahmed H, Kamran J. Post-Percutaneous Transluminal Coronary Angioplasty Acute Dyspnea in Acute Coronary Syndrome Patients: Ticagrelor versus Clopidogrel at Tertiary Cardiac Center: A Cross-Sectional Study. Life and Science. 2026;7(3):7. doi:10.37185/lns.1.1.1185

BibTeX
@article{Ashraf2026,
  author = {Ashraf, Tehreem and Bhatti, Qamar Uz Zaman and Siddique, Muhammad Bilal and Mushtaq, Huma and Ahmed, Hira and Kamran, Javeria},
  title = {Post-Percutaneous Transluminal Coronary Angioplasty Acute Dyspnea in Acute Coronary Syndrome Patients: Ticagrelor versus Clopidogrel at Tertiary Cardiac Center: A Cross-Sectional Study},
  journal = {Life and Science},
  year = {2026},
  volume = {7},
  number = {3},
  pages = {7},
  doi = {10.37185/lns.1.1.1185}
}
Kostenlos starten →